CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

SLE · Systemic Lupus Erythematosus (SLE) · CAR T Cell · CART19 · Cell Therapy · Lupus · Lupus Nephritis (LN)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Caitlin Elgarten, MD) · elgartenc@chop.edu · 267-425-7964
Contact: Study coordinator (Melissa Varghese) · varghesem@chop.edu · 845-553-5358
Contact: Principal Investigator (Caitlin Elgarten, MD)

Study leads

Caitlin Elgarten, MD
Principal Investigator
Children's Hospital of Philadelphia

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Lupus Landmark Study: A Prospective Registry and Biorepository

Systemic Lupus Erythematosus (SLE) · Lupus Nephritis · Neuropsychiatric Systemic Lupus Erythematosus

Abroad (travel likely)Recruiting

Birmingham, United States · Tucson, United States

US Zamto-cel Autoimmune Diseases

Lupus Nephritis · Systemic Lupus Erythematosus · Systemic Sclerosis (SSc)

Abroad (travel likely)RecruitingPHASE1

Milwaukee, United States

A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM)

Systemic Lupus Erythematosus (SLE) · Idiopathic Inflammatory Myopathies(IIM)

Abroad (travel likely)RecruitingPHASE1

Bengbu, China · Guangzhou, China

Clinical Study of Cizutamig in Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE)

Abroad (travel likely)RecruitingPHASE1

Beijing, China